Cargando…

Localized periorbital edema as a clinical manifestation of sulfite sensitivity.

Sulfite is commonly used in pharmaceuticals as a preservative. We report a unique clinical presentation of localized periorbital edema on the left eye after administration of sulfite-containing dexamethasone. The patient's sulfite sensitivity was confirmed by sulfite oral provocation test: peri...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, H. S., Nahm, D.
Formato: Texto
Lenguaje:English
Publicado: Korean Academy of Medical Sciences 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054089/
https://www.ncbi.nlm.nih.gov/pubmed/8878807
_version_ 1782199861565718528
author Park, H. S.
Nahm, D.
author_facet Park, H. S.
Nahm, D.
author_sort Park, H. S.
collection PubMed
description Sulfite is commonly used in pharmaceuticals as a preservative. We report a unique clinical presentation of localized periorbital edema on the left eye after administration of sulfite-containing dexamethasone. The patient's sulfite sensitivity was confirmed by sulfite oral provocation test: periorbital edema on the same site developed after ingestion of 200 mg sodium bisulfite. She was non-atopic and did not complain of any respiratory symptoms. Allergy skin prick test with 100 mg/ml sodium bisulfite showed a negative result. She also has aspirin-sensitive urticaria which was confirmed by oral provocation test. In conclusion, sulfite can induce a localized periorbital edema, an uncommon manifestation in sensitive patients. Further investigations are needed to clarify the pathogenetic mechanisms.
format Text
id pubmed-3054089
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-30540892011-03-15 Localized periorbital edema as a clinical manifestation of sulfite sensitivity. Park, H. S. Nahm, D. J Korean Med Sci Research Article Sulfite is commonly used in pharmaceuticals as a preservative. We report a unique clinical presentation of localized periorbital edema on the left eye after administration of sulfite-containing dexamethasone. The patient's sulfite sensitivity was confirmed by sulfite oral provocation test: periorbital edema on the same site developed after ingestion of 200 mg sodium bisulfite. She was non-atopic and did not complain of any respiratory symptoms. Allergy skin prick test with 100 mg/ml sodium bisulfite showed a negative result. She also has aspirin-sensitive urticaria which was confirmed by oral provocation test. In conclusion, sulfite can induce a localized periorbital edema, an uncommon manifestation in sensitive patients. Further investigations are needed to clarify the pathogenetic mechanisms. Korean Academy of Medical Sciences 1996-08 /pmc/articles/PMC3054089/ /pubmed/8878807 Text en
spellingShingle Research Article
Park, H. S.
Nahm, D.
Localized periorbital edema as a clinical manifestation of sulfite sensitivity.
title Localized periorbital edema as a clinical manifestation of sulfite sensitivity.
title_full Localized periorbital edema as a clinical manifestation of sulfite sensitivity.
title_fullStr Localized periorbital edema as a clinical manifestation of sulfite sensitivity.
title_full_unstemmed Localized periorbital edema as a clinical manifestation of sulfite sensitivity.
title_short Localized periorbital edema as a clinical manifestation of sulfite sensitivity.
title_sort localized periorbital edema as a clinical manifestation of sulfite sensitivity.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054089/
https://www.ncbi.nlm.nih.gov/pubmed/8878807
work_keys_str_mv AT parkhs localizedperiorbitaledemaasaclinicalmanifestationofsulfitesensitivity
AT nahmd localizedperiorbitaledemaasaclinicalmanifestationofsulfitesensitivity